Showing results (11-20 of 206) with videos related to
Sort By:
Pageof 21
Virus Research|July 31, 2012
Coordinated and sequential transcription of the cyprinid herpesvirus-3 annotated genesMaya Ilouze, Arnon Dishon, Moshe KotlerVirus Research|July 31, 2012
Down-regulation of the cyprinid herpesvirus-3 annotated genes in cultured cells maintained at restrictive high temperatureMaya Ilouze, Arnon Dishon, Moshe KotlerJournal of Virology|February 16, 2007
Persistence of cyprinid herpesvirus 3 in infected cultured carp cellsArnon Dishon, Maya Davidovich, Maya Ilouze, et al.Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
Rare targetable drivers (RTDs) in non-small cell lung cancer (NSCLC): Outcomes with immune check-point inhibitors (ICPi)Elizabeth Dudnik, Elias Bshara, Ahuva Grubstein, et al.FEBS Letters|July 25, 2006
Cyprinid herpes virus-3 (CyHV-3) bears genes of genetically distant large DNA virusesMaya Ilouze, Arnon Dishon, Tamar Kahan, et al.Breathe (Sheffield, England)|June 8, 2018
Assembly 11: thoracic oncologyClementine Bostantzoglou, Nir PeledVaccine|June 7, 2008
Antibody response and resistance of Cyprinus carpio immunized with cyprinid herpes virus 3 (CyHV-3)Ayana Perelberg, Maya Ilouze, Moshe Kotler, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 20, 2018
The Clinical Impact of Comprehensive Genomic Testing of Circulating Cell-Free DNA in Advanced Lung CancerSmadar Laufer-Geva, Anna Belilovski Rozenblum, Tal Twito, et al.Lung Cancer (Auckland, N.Z.)|May 30, 2017
Exhaled breath analysis for the early detection of lung cancer: recent developments and future prospectsInbar Nardi-Agmon, Nir PeledHarefuah|October 21, 2015
[LUNG CANCER TREATMENT IN 2015: ADVANCES AND FUTURE OUTLOOK]Nir Peled, Anna Belilovski RozenblumPageof 21